Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination

Protein Science : a Publication of the Protein Society
T StamsD W Christianson

Abstract

Carbonic anhydrase IV (CAIV) is a membrane-associated enzyme anchored to plasma membrane surfaces by a phosphatidylinositol glycan linkage. We have determined the 2.8-angstroms resolution crystal structure of a truncated, soluble form of recombinant murine CAIV. We have also determined the structure of its complex with a drug used for glaucoma therapy, the sulfonamide inhibitor brinzolamide (Azopt). The overall structure of murine CAIV is generally similar to that of human CAIV; however, some local structural differences are found in the active site resulting from amino acid sequence differences in the "130's segment" and the residue-63 loop (these may affect the nearby catalytic proton shuttle, His-64). Similar to human CAIV, the C-terminus of murine CAIV is surrounded by a substantial electropositive surface potential that may stabilize the interaction with the phospholipid membrane. Binding interactions observed for brinzolamide rationalize the generally weaker affinity of inhibitors used in glaucoma therapy toward CAIV compared with CAII.

References

Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T OkuyamaW S Sly
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G S HagemanW S Sly
Jul 22, 1991·Biochimica Et Biophysica Acta·W F BrechueT H Maren
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S SatoW S Sly
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D BrownW S Sly
Dec 1, 1990·International Journal of Biological Macromolecules·J VidgrenN P Walker
Feb 2, 1972·Nature: New Biology·A LiljasM Petef
Apr 28, 1968·Journal of Molecular Biology·B W Matthews
Jan 1, 1984·Annals of the New York Academy of Sciences·K K KannanT A Jones
Jul 1, 1981·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·R M EffrosP Silverman
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·P A Boriack-SjodinD W Christianson
Jan 1, 1995·Annual Review of Biochemistry·W S Sly, P Y Hu
May 26, 1995·Science·B Honig, A Nicholls
Jan 1, 1994·Protein Science : a Publication of the Protein Society·G M SmithC N Habecker
Jan 1, 1994·Archives of Ophthalmology·J M TielschJ C Javitt
Apr 15, 1993·The New England Journal of Medicine·H A Quigley
May 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S ParkkilaH Rajaniemi
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·T StamsD W Christianson
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·S TamaiW S Sly
Mar 4, 1997·Biochemistry·T T BairdC A Fierke
May 23, 1997·The Journal of Biological Chemistry·J D HurtD N Silverman
Nov 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·E A Merritt, M E Murphy
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Jan 23, 1987·Science·A T BrüngerM Karplus

❮ Previous
Next ❯

Citations

Dec 29, 1998·Protein Science : a Publication of the Protein Society·P A Boriack-SjodinD W Christianson
Oct 26, 2001·Biochemical and Biophysical Research Communications·T WingoD N Silverman
Feb 9, 2000·Survey of Ophthalmology·L DeSantis
Feb 13, 2001·International Journal of Biological Macromolecules·M CeolínM R Ermácora
Nov 11, 1999·Biochimica Et Biophysica Acta·M QianD N Silverman
Oct 6, 2000·Journal of Molecular Graphics & Modelling·E X EspositoJ D Madura
Dec 30, 1999·Progress in Retinal and Eye Research·M F Sugrue
Apr 5, 2007·Journal of the American Chemical Society·D K SrivastavaDavid W Christianson
Aug 9, 2001·Proceedings of the National Academy of Sciences of the United States of America·D A WhittingtonD W Christianson
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·O DymD Eisenberg
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·B UlmasovD N Silverman
Apr 8, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Antonio Martínez, Manuel Sánchez-Salorio
Jul 31, 2013·Acta Crystallographica. Section D, Biological Crystallography·Christopher D BooneRobert McKenna
May 27, 2009·Virology Journal·Jolanda M P LiefhebberHans C van Leeuwen
Oct 27, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Stefano Forli
Mar 31, 2010·Current Medical Research and Opinion·Konstantin Gugleta
Apr 4, 2016·Bioorganic Chemistry·Subhalakshmi KalyanavenkataramanGeetha B Kumar
Feb 3, 2005·Bioorganic & Medicinal Chemistry Letters·Alessio InnocentiClaudiu T Supuran
Dec 29, 2007·ChemMedChem·Katia D'AmbrosioGiuseppina De Simone
Mar 16, 2017·Scientific Reports·Yoshikazu IkutaHitoshi Kasai
Feb 8, 2002·Journal of Medicinal Chemistry·Chu-Young KimDavid W Christianson
Sep 25, 2004·Bioorganic & Medicinal Chemistry·Milan Remko, Claus-Wilhelm von der Lieth
Apr 29, 2011·Bioorganic & Medicinal Chemistry·Zhonghai XiaoHai Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.